Lopinavir troughs lower in children on once-daily dose with efavirenz
1 May 2011. Related: Conference reports, Antiretrovirals, Paediatric care.
Conference reports
Dose optimisation: 50 mg ritonavir-boosting, 3TC dosing and raltegravir once-daily
1 May 2011. Related: Conference reports, Antiretrovirals, Treatment strategies.
46th European Association for the Study of the Liver (EASL), 30 March-3 April 2011, Berlin, Germany
1 May 2011. Related: Conference reports.
Rapid report: state of HCV policy, treatment, access
1 May 2011. Related: Conference reports, Antiretrovirals.
18th Conference on Retroviruses and Opportunistic Infections (CROI), 27 February-3 March 2011, Boston
1 May 2011. Related: Conference reports.
When to start ART in patients co-infected with TB: results from two trials presented at CROI
1 May 2011. Related: Conference reports, Antiretrovirals, TB coinfection.
Inflammation and intervention: how does HIV cause AIDS and how does it cause disease despite ART
1 May 2011. Related: Conference reports, Antiretrovirals.
18th Conference on Retroviruses and Opportunistic Infections (CROI), 27 February-3 March 2011, Boston
1 April 2011. Related: Conference reports.
New antiretrovirals: dolutegravir, entry inhibitor (BMS-663068) and tenofovir pro-drug (GS-7340)
1 April 2011. Related: Conference reports, Antiretrovirals.
Immune-based treatment increases HIV-resistant CD4 cells in phase 1 study
1 April 2011. Related: Conference reports, Antiretrovirals.
Antiretroviral prevention: oral PrEP, gels and treatment studies
1 April 2011. Related: Conference reports, Antiretrovirals.
Further efficacy analyses from the iPrEx study
1 April 2011. Related: Conference reports, Antiretrovirals.
Topical gels as PEP and PrEP: animal and human studies
1 April 2011. Related: Conference reports, Antiretrovirals.
Maternal risk following short course HAART
1 April 2011. Related: Conference reports, Antiretrovirals, Pregnancy.
Pre-term delivery and HAART
1 April 2011. Related: Conference reports, Antiretrovirals, Pregnancy.
HAART more effective than AZT monotherapy in the Botswana PMTCT programme
1 April 2011. Related: Conference reports, Antiretrovirals, Pregnancy.
Lopinavir/r monotherapy for PMTCT
1 April 2011. Related: Conference reports, Antiretrovirals, Pregnancy.
No evidence of increased risk of MTCT with sequential pregnancies in UK and Ireland
1 April 2011. Related: Conference reports, Pregnancy.
Recently infected women at the time of delivery have a higher rate of in-utero transmission in PEPI-Malawi
1 April 2011. Related: Conference reports, Pregnancy.
Reduced CCL22 concentrations in cervicovaginal secretions from pregnant women
1 April 2011. Related: Conference reports, Pregnancy.
First results from telaprevir in HIV/HCV coinfection
1 April 2011. Related: Conference reports, Antiretrovirals, Hepatitis coinfection.
HCV reinfection rates in HIV-positive gay men
1 April 2011. Related: Conference reports.
1st International Workshop on HIV and Women, 10-11 January 2011, Washington
1 February 2011. Related: Conference reports.
Lopinavir/ritonavir: women versus men
1 February 2011. Related: Conference reports, Antiretrovirals, Women's health.
Quality of life in the GRACE study
1 February 2011. Related: Conference reports, Antiretrovirals, Women's health.
Antiretroviral pharmacokinetics in women with undetectable viral load
1 February 2011. Related: Conference reports, Antiretrovirals, Women's health.
No association between bone mineral density and lipodystrophy in women receiving antiretroviral therapy
1 February 2011. Related: Conference reports, Antiretrovirals, Women's health, Weight, diabetes, metabolic complications.
The impact of antiretroviral treatment on fertility intentions in South Africa
1 February 2011. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.
41st Union World Conference on Lung Health, 11-15 November 2010, Berlin
1 February 2011. Related: Conference reports, TB coinfection.
Faster conversion rates with TMC-207 versus placebo plus OBT for the treatment of MDR-TB
1 February 2011. Related: Conference reports, TB coinfection.
Xpert MTB-RIF validation study from Tanzania
1 February 2011. Related: Conference reports, TB coinfection.
GeneXpert demonstrates good sensitivity and specificity but at high cost
1 February 2011. Related: Conference reports, TB coinfection.
12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, 4-6 November 2010, London
1 February 2011. Related: Conference reports.
Intestinal microflora and low grade metabolic inflammation
1 February 2011. Related: Conference reports, Weight, diabetes, metabolic complications.
Complex connections between bone and fat metabolism
1 February 2011. Related: Conference reports, PK and drug interactions, Weight, diabetes, metabolic complications.
10th International Congress on Drug Therapy in HIV Infection, 7-11 November 2010, Glasgow
1 December 2010. Related: Conference reports.
Virological findings from the SARA trial ofboosted protease inhibitor monotherapy
1 December 2010. Related: Conference reports, Antiretrovirals, Treatment access, Virology.
Nevirapine exposure was not associated with hypersensitivity in patients from Malawi
1 December 2010. Related: Conference reports, Antiretrovirals, Side effects.
Estimating the number of people in a country or region with HIV who are undiagnosed and in need of ART
1 December 2010. Related: Conference reports, Antiretrovirals.
Highpreterm delivery rates associated with initiation of HAART during pregnancy at a London clinic
1 December 2010. Related: Conference reports, Pregnancy.
Minority M184V variants detected in women after receiving 3TC/FTC and LPV/r-containing regimens in pregnancy
1 December 2010. Related: Conference reports, Pregnancy, Drug resistance.
The Antiretroviral Pregnancy Registry reports no increased rate of birth defects with atazanavir exposure
1 December 2010. Related: Conference reports, Pregnancy.
Pharmacokinetics of lopinavir/ritonavir incombination with rifampicin based TB treatment in children
1 December 2010. Related: Conference reports, Paediatric care, PK and drug interactions, TB coinfection.
Efavirenz versus nevirapine based first linetreatment in a South African cohort
1 December 2010. Related: Conference reports, Antiretrovirals, Pregnancy.
GSK572: 24-week results in treatment-naive and raltegravir-experienced patients
1 December 2010. Related: Conference reports, Antiretrovirals.
Consensus guidelines recommend routine use of genotypic tropism testing: new focus on maraviroc as a switching option (2010)
1 December 2010. Related: Conference reports, Antiretrovirals, Guidelines.
UK studies on bone health: increasedfracture rates reported in HIV-positive people
1 December 2010. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
Muscle weakness or pain analysed as possible raltegravir side effect
1 December 2010. Related: Conference reports, Antiretrovirals, Side effects.
Adding maraviroc does not boost CD4s inrandomised trial
1 December 2010. Related: Conference reports, Antiretrovirals.
Switch to twice-daily unboosted atazanavir outdoes switch to once-daily dose
1 December 2010. Related: Conference reports, Antiretrovirals.
Small but higher rates of AIDS and non-AIDS complications with uncontrolled HIV despite CD4s over 350
1 December 2010. Related: Conference reports, Antiretrovirals.
12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, 4-6 November 2010, London
1 December 2010. Related: Conference reports, Weight, diabetes, metabolic complications.
Bio-Alcamid associated with unacceptable risk of complications: no longer recommended as a treatment for facial lipoatrophy
1 December 2010. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
First International Workshop on HIV and Ageing, 4-5 October 2010, Baltimore
1 December 2010. Related: Conference reports.
T-cell senescence linked to KS in peoplewith good HIV control
1 December 2010. Related: Conference reports, Cancer and HIV, Basic science and immunology.
Higher risk of potential drug-drug interactions in HIV patients over 60
1 December 2010. Related: Conference reports, PK and drug interactions.
Age raises fracture risk more in HIV-positive people
1 December 2010. Related: Conference reports, Weight, diabetes, metabolic complications.
50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 12-15 September 2010, Boston
1 October 2010. Related: Conference reports.
Raltegravir pharmacokinetics inpregnancy
1 October 2010. Related: Conference reports, Antiretrovirals, Pregnancy.
Low birth weight associated with HAART in pregnancy in Zambia
1 October 2010. Related: Conference reports, Antiretrovirals, Pregnancy.
Bilirubin levels in infants following in utero atazanavir exposure compared to exposure to other antiretrovirals
1 October 2010. Related: Conference reports, Antiretrovirals, Pregnancy.
Novel mutations and shifting susceptibility to darunavir and tipranavir
1 October 2010. Related: Conference reports, Antiretrovirals, Drug resistance.
Four-drug single-pill antiretroviral equivalent to Atripla at 48 weeks
1 October 2010. Related: Conference reports, Antiretrovirals.
High rates of bone loss and progression with HIV in longitudinal study
1 October 2010. Related: Conference reports, Antiretrovirals, Side effects.
XVIII International AIDS Conference: 18-23 July 2010, Vienna
1 October 2010. Related: Conference reports.